Literature DB >> 16041899

Validation of the care notebook for measuring physical, mental and life well-being of patients with cancer.

Kunihiko Kobayashi1, Joseph Green, Mari Shimonagayoshi, Noriaki Kanemoto, Ryo Kasai, Yoichi Itoh, Yuki Fujiki, Yasuo Ohashi, Carolyn Gotay, Shoji Kudoh.   

Abstract

To measure patients' QOL in the daily practice of clinical oncology, we developed and tested the Care Notebook. This instrument has 24 questions expressed in single words or short phrases to make it more acceptable to patients. The Care Notebook, EORTC QLQ-C30 and FACIT-Sp-12 were administered to 249 outpatients with cancer. Construct validity was investigated by cluster analysis and multitrait scaling analysis. The results showed that three scales (physical well-being, mental well-being, and life well-being) could explain 55% of the variance in scores. The life well-being scale could be divided into subscales of Daily Functioning, Social Functioning, and Subjective QOL. Multitrait scaling analysis confirmed convergent and discriminant validity of these scales and subscales. Internal consistency and test-retest reliability were favorable. Differences in Care Notebook scores were also consistent with differences in performance status rating (known-groups validity), and Care Notebook scores correlated with EORTC QLQ-C30 and FACT-Sp-12 scores (concurrent validity). The Care Notebook allows clinical oncologists to easily collect valid and reliable QOL information of physical, mental, and life well-being repeatedly and with minimal burden on patients.

Entities:  

Mesh:

Year:  2005        PMID: 16041899     DOI: 10.1007/s11136-004-2958-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  21 in total

1.  A diary form quality of life questionnaire for Japanese patients with lung cancer and summarization techniques for longitudinal assessment.

Authors:  Y Ishihara; H Sakai; N Nukariya; K Kobayashi; S Yoneda; R Matsuoka; T Hohjo; Y Nishiwaki; A Hoshi; Y Kuratomi; A Nagai; J Kagawa; S Kitamura
Journal:  Respirology       Date:  1999-03       Impact factor: 6.424

Review 2.  Personality, culture, and subjective well-being: emotional and cognitive evaluations of life.

Authors:  Ed Diener; Shigehiro Oishi; Richard E Lucas
Journal:  Annu Rev Psychol       Date:  2002-06-10       Impact factor: 24.137

3.  A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer.

Authors:  K Kobayashi; F Takeda; S Teramukai; I Gotoh; H Sakai; S Yoneda; Y Noguchi; H Ogasawara; K Yoshida
Journal:  Eur J Cancer       Date:  1998-05       Impact factor: 9.162

4.  The use of quality of life data in clinical practice.

Authors:  J Morris; D Perez; B McNoe
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

5.  Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial.

Authors:  Symone B Detmar; Martin J Muller; Jan H Schornagel; Lidwina D V Wever; Neil K Aaronson
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

Review 6.  Recent developments and future issues in the use of health status assessment measures in clinical settings.

Authors:  S Greenfield; E C Nelson
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

7.  Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese.

Authors:  H Fumimoto; K Kobayashi; C H Chang; S Eremenco; Y Fujiki; S Uemura; Y Ohashi; S Kudoh
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

9.  The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in japanese patients with advanced non-small-cell lung cancer.

Authors:  T Matsumoto; Y Ohashi; S Morita; K Kobayashi; M Shibuya; Y Yamaji; K Eguchi; M Fukuoka; K Nagao; Y Nishiwaki; H Niitani
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

10.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial.

Authors:  Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

View more
  12 in total

Review 1.  Assessing the social impact of cancer: a review of available tools.

Authors:  Barbara Muzzatti; M Antonietta Annunziata
Journal:  Support Care Cancer       Date:  2012-08-07       Impact factor: 3.603

2.  Pediatric advance care planning (pACP) for teens with cancer and their families: Design of a dyadic, longitudinal RCCT.

Authors:  Katherine B Curtin; Anne E Watson; Jichuan Wang; Obianuju C Okonkwo; Maureen E Lyon
Journal:  Contemp Clin Trials       Date:  2017-08-24       Impact factor: 2.226

3.  Shared spiritual beliefs between adolescents with cancer and their families.

Authors:  Jessica Livingston; Yao I Cheng; Jichuan Wang; Matthew Tweddle; Sarah Friebert; Justin N Baker; Jessica Thompkins; Maureen E Lyon
Journal:  Pediatr Blood Cancer       Date:  2020-09-12       Impact factor: 3.167

4.  Verification of the psychometric properties of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 palliative (EORTCQLQ-C15-PAL).

Authors:  Kikuko Miyazaki; Yoshimi Suzukamo; Kojiro Shimozuma; Takeo Nakayama
Journal:  Qual Life Res       Date:  2011-06-04       Impact factor: 4.147

5.  Conceptual equivalence and health-related quality of life: an exploratory study in Japanese and Dutch cancer patients.

Authors:  W Chr Kleijn; K Ogoshi; K Yamaoka; T Shigehisa; Y Takeda; C L Creutzberg; J W R Nortier; A A Kaptein
Journal:  Qual Life Res       Date:  2006-08       Impact factor: 4.147

Review 6.  Patient-Reported Physical Function Measures in Cancer Clinical Trials.

Authors:  Thomas M Atkinson; Angela M Stover; Daniel F Storfer; Rebecca M Saracino; Thomas A D'Agostino; Denise Pergolizzi; Konstantina Matsoukas; Yuelin Li; Ethan Basch
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

7.  Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial.

Authors:  Satoshi Oizumi; Kunihiko Kobayashi; Akira Inoue; Makoto Maemondo; Shunichi Sugawara; Hirohisa Yoshizawa; Hiroshi Isobe; Masao Harada; Ichiro Kinoshita; Shoji Okinaga; Terufumi Kato; Toshiyuki Harada; Akihiko Gemma; Yasuo Saijo; Yuki Yokomizo; Satoshi Morita; Koichi Hagiwara; Toshihiro Nukiwa
Journal:  Oncologist       Date:  2012-05-11

8.  Effects of a Self-Monitoring Quality of Life Intervention in Outpatients with Breast Cancer: A Preliminary Report of A Randomized Controlled Trial.

Authors:  Ayako Matsuda; Kenichi Inoue; Manami Momiyama; Kobayashi Kunihiko; Kaoru Kubota; Soerindra S R S Ramai; Maarten J Fischer; Judith R Kroep; Adrian A Kaptein; Kazue Yamaoka
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

9.  Effectiveness of a Self-Monitoring Quality of Life Intervention For Patients with Cancer Receiving Palliative Care: A Randomized Controlled Clinical Trial.

Authors:  Ayako Matsuda; Yosuke Yamada; Noriko Ishizuka; Eisuke Matsushima; Kunihiko Kobayashi; Takayoshi Ohkubo; Kazue Yamaoka
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

Review 10.  Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC).

Authors:  Kunihiko Kobayashi; Koichi Hagiwara
Journal:  Target Oncol       Date:  2013-01-30       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.